Kymera Therapeutics Inc
(NASDAQ:KYMR)
$15.25
0[0.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$15.02
-0.2300[-1.51%]
Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kymera Therapeutics Stock (NASDAQ:KYMR), Quotes and News Summary

Kymera Therapeutics Stock (NASDAQ: KYMR) stock price, news, charts, stock research, profile.

Open-Close-
Vol / Avg.0 / 397.053KMkt Cap845.038M
Day Range- - -52 Wk Range14.965 - 39.850
Full archive of press releases available on Benzinga Pro
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q3 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q2 2023Est.ActualSurprise
EPS-0.710-0.670 0.0400
REV14.060M16.513M2.453M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2023-08-29Morgan StanleyJames QuigleyMaintainsEqual-WeightEqual-WeightLowers39.0037.00
2023-08-07StifelBradley CaninoMaintainsBuyBuyRaises48.0052.00
2023-08-04Credit SuisseRichard LawMaintainsNeutralNeutralRaises36.0037.00
2023-08-04HC Wainwright & Co.Andrew FeinReiteratesBuyBuyMaintains-85.00

Related Companies

TickerCompanyChg %Mkt Cap
KYMRKymera Therapeutics0%845M
VALNValneva0%880.6M
COGTCogent Biosciences0%852.1M
AMAMAmbrx Biopharma0%666M
REPLReplimune Group0%952.8M
Q

How do I buy Kymera Therapeutics (KYMR) stock?

A

You can purchase shares of Kymera Therapeutics (NASDAQ: KYMR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Kymera Therapeutics's (KYMR) competitors?

Q

What is the target price for Kymera Therapeutics (KYMR) stock?

A

The latest price target for Kymera Therapeutics (NASDAQ: KYMR) was reported by Morgan Stanley on Tuesday, August 29, 2023. The analyst firm set a price target for 37.00 expecting KYMR to rise to within 12 months (a possible 142.62% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Kymera Therapeutics (KYMR)?

A

The stock price for Kymera Therapeutics (NASDAQ: KYMR) is $15.25 last updated September 25, 2023 at 8:00 PM UTC.

Q

Does Kymera Therapeutics (KYMR) pay a dividend?

A

There is no dividend information for Kymera Therapeutics.

Q

When is Kymera Therapeutics (NASDAQ:KYMR) reporting earnings?

A

Kymera Therapeutics’s Q3 earnings are confirmed for Thursday, November 2, 2023.

Q

Is Kymera Therapeutics (KYMR) going to split?

A

There is no upcoming split for Kymera Therapeutics.

Q

What sector and industry does Kymera Therapeutics (KYMR) operate in?

A

Kymera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.